Pharmaceutical Executive, Mar 1, 2013 - Pharmaceutical Executive

ADVERTISEMENT
Pharmaceutical Executive, Mar 1, 2013
Features
Specialty Service Programs: Gearing up for Next Generation Technologies
By Rujul Desai , Partha Anbil
Innovation in hub program design for patient scrip data and clinical support services can lead to increased market share in the hotly contested specialty medicine space.
Pharma in the News: Pharm Exec's Annual Press Audit
By George P. Sillup , Stephen J. Porth
Big Pharma takes a fresh licking in our latest audit of US press coverage of business and policy issues.
Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist?
By Ken Getz
Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
Brand of the Year: Januvia
By Ben Comer
In 2012, Merck's diabetes franchise became the highest-selling product family in its 122-year history.
China and the Emerging Markets Challenge
By Rachel Lee , Martin Reeves
Chinese policies are to pose new opportunities and challenges for Big Pharma companies active in the country.
Columns
Another Round of FDA Legislation?
By Jill Wechsler
Pressure for action on key enforcement and regulatory issues may prompt congressional action this year.
Less Selling, More Time
By Al Topin
What can happen when reps focus on the physician-patient conversation? Al Topin reports.
Safeguarding the Value of Patent Assets
By Mary Henninger , Mark Feldstein
As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.
Who's Really in Charge of European Drug Registration?
By Reflector
European Commision blocks the authorization of a life-saving liver drug outside of France.
Early Engagement with Medical Laboratories
By Peter Keeling , Maria Fe Paz
Timely engagement is the key to expanding the use of companion diagnostics.
Embedding Market Access in Today's Pharma Business Model
By Alyse Forcellina , Can Akannac
A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
Test and Learn: Making Confident Decisions on the Commercial Side
By Ben Bonifant , Scott Setrakian
Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.
Country Report
Country Report: China
China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest. By 2015, China will pass Japan to rival only the United States for number one.

ADVERTISEMENT

Click here